Related Experiment Video
Updated: Aug 9, 2026
09:01
Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles
Published on: September 27, 2013
Angiogenic and antiangiogenic gene therapy
M Malecki1, P Kolsut, R Proczka
1Department of Cell Biology, Centre of Oncology, Maria Sklodowska-Curie Memorial Institute, Warsaw, Poland.
Gene Therapy
|October 19, 2005
Summary
Gene therapy using plasmid DNA shows promise for treating cardiovascular diseases by promoting new vessel formation (angiogenesis). Further research is needed to establish therapeutic angiogenesis as a standard treatment option.
Area of Science:
- Molecular Biology
- Cardiovascular Medicine
- Oncology
Background:
- Gene therapy offers a promising avenue for treating diseases.
- Angiogenesis, the formation of new blood vessels, is a key target for therapeutic intervention.
- Angiogenic and antiangiogenic gene therapies are emerging approaches for cardiovascular diseases and cancer, respectively.
Purpose of the Study:
- To explore the potential of gene therapy in modulating angiogenesis for therapeutic benefit.
- To review the current status of angiogenic gene therapy in preclinical and clinical settings, particularly for cardiovascular conditions.
Main Methods:
- Utilizing plasmid vectors for gene delivery in angiogenic gene therapy.
- Employing naked plasmid DNA to transfect skeletal muscles or heart tissue.
- Expressing angiogenic genes to stimulate new vessel formation.
Main Results:
- Successful transfection of muscle and heart tissues with naked plasmid DNA.
- Demonstrated expression of angiogenic genes leading to new vessel formation.
- Observed improvement in the clinical condition of patients in preliminary studies.
Conclusions:
- Preliminary clinical data for angiogenic gene therapy are encouraging.
- Further research and advancements in gene delivery systems are crucial.
- Therapeutic angiogenesis and antiangiogenic methods may become supplemental or alternative treatments for angiogenic diseases.
Related Concept Videos
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.